ID   IL18_RAT                Reviewed;         194 AA.
AC   P97636; O88749; P97637; Q541E6;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   02-OCT-2024, entry version 154.
DE   RecName: Full=Interleukin-18;
DE            Short=IL-18;
DE   AltName: Full=Interferon gamma-inducing factor;
DE            Short=IFN-gamma-inducing factor;
DE   AltName: Full=Interleukin-1 gamma;
DE            Short=IL-1 gamma;
DE   Flags: Precursor;
GN   Name=Il18; Synonyms=Igif;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA).
RC   STRAIN=Sprague-Dawley; TISSUE=Adrenal gland;
RX   PubMed=8999896; DOI=10.1074/jbc.272.4.2035;
RA   Conti B., Jahng J.W., Tinti C., Son J.H., Joh T.H.;
RT   "Induction of interferon-gamma inducing factor in the adrenal cortex.";
RL   J. Biol. Chem. 272:2035-2037(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9702748; DOI=10.1038/sj.mp.4000389;
RA   Culhane A.C., Hall M.D., Rothwell N.J., Luheshi G.N.;
RT   "Cloning of rat brain interleukin-18 cDNA.";
RL   Mol. Psychiatry 3:362-366(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA).
RC   STRAIN=New England Deaconess Hospital; TISSUE=Adrenal gland;
RA   Kim S.-J., Kim C.-S., Song K.-Y., Kim J.-S., Jung K.-S.;
RT   "Cloning of the cDNA for interleukin-18 in PC12 and expression in
RT   Escherichia coli.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA).
RC   STRAIN=Fischer 344;
RX   PubMed=12787406; DOI=10.1046/j.1523-1755.2003.00077.x;
RA   Garcia G.E., Xia Y., Ku G., Johnson R.J., Wilson C.B., Feng L.;
RT   "IL-18 translational inhibition restricts IFN-gamma expression in
RT   crescentic glomerulonephritis.";
RL   Kidney Int. 64:160-169(2003).
CC   -!- FUNCTION: Pro-inflammatory cytokine primarily involved in epithelial
CC       barrier repair, polarized T-helper 1 (Th1) cell and natural killer (NK)
CC       cell immune responses. Upon binding to IL18R1 and IL18RAP, forms a
CC       signaling ternary complex which activates NF-kappa-B, triggering
CC       synthesis of inflammatory mediators. Synergizes with IL12/interleukin-
CC       12 to induce IFNG synthesis from T-helper 1 (Th1) cells and natural
CC       killer (NK) cells. Involved in transduction of inflammation downstream
CC       of pyroptosis: its mature form is specifically released in the
CC       extracellular milieu by passing through the gasdermin-D (GSDMD) pore.
CC       {ECO:0000250|UniProtKB:Q14116}.
CC   -!- SUBUNIT: Forms a ternary complex with ligand-binding receptor subunit
CC       IL18R1 and signaling receptor subunit IL18RAP at the plasma membrane.
CC       Mature IL18 first binds to IL18R1 forming a low affinity binary
CC       complex, which then interacts with IL18RAP to form a high affinity
CC       ternary complex that signals inside the cell. Interacts with cargo
CC       receptor TMED10; the interaction mediates the translocation from the
CC       cytoplasm into the ERGIC (endoplasmic reticulum-Golgi intermediate
CC       compartment) and thereby secretion. {ECO:0000250|UniProtKB:Q14116}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q14116}. Secreted
CC       {ECO:0000250|UniProtKB:Q14116}. Note=The precursor is cytosolic. In
CC       response to inflammasome-activating signals, cleaved and secreted.
CC       Mature form is secreted and released in the extracellular milieu by
CC       passing through the gasdermin-D (GSDMD) pore. In contrast, the
CC       precursor form is not released, due to the presence of an acidic region
CC       that is proteolytically removed by CASP1 during maturation. The
CC       secretion is dependent on protein unfolding and facilitated by the
CC       cargo receptor TMED10. {ECO:0000250|UniProtKB:Q14116}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Beta;
CC         IsoId=P97636-1; Sequence=Displayed;
CC       Name=Alpha;
CC         IsoId=P97636-2; Sequence=VSP_002659;
CC   -!- PTM: The pro-IL-18 precursor is processed by CASP1 to yield its mature,
CC       active form. The pro-IL-18 precursor is however not processed by
CC       Casp4/Casp11 in rodents (By similarity). The pro-IL-18 precursor
CC       features autoinhibitory interactions between the propeptide and the
CC       post-cleavage-site region, preventing recognition by the IL18R1
CC       receptor. Processing by CASP1 induces conformational changes to
CC       generate critical receptor-binding sites. The mature form is then
CC       secreted and released in the extracellular milieu by passing through
CC       the gasdermin-D (GSDMD) pore. In contrast, cleavage by CASP3
CC       inactivates IL18 (By similarity). {ECO:0000250|UniProtKB:P70380,
CC       ECO:0000250|UniProtKB:Q14116}.
CC   -!- SIMILARITY: Belongs to the IL-1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U77776; AAC53009.1; -; mRNA.
DR   EMBL; U77777; AAC53010.1; -; mRNA.
DR   EMBL; AJ222813; CAA11001.1; -; mRNA.
DR   EMBL; AY258448; AAP14669.1; -; mRNA.
DR   EMBL; AY077842; AAL77211.1; -; mRNA.
DR   RefSeq; NP_062038.1; NM_019165.1.
DR   AlphaFoldDB; P97636; -.
DR   SMR; P97636; -.
DR   STRING; 10116.ENSRNOP00000013093; -.
DR   BindingDB; P97636; -.
DR   PhosphoSitePlus; P97636; -.
DR   PaxDb; 10116-ENSRNOP00000013093; -.
DR   GeneID; 29197; -.
DR   KEGG; rno:29197; -.
DR   UCSC; RGD:2889; rat. [P97636-1]
DR   AGR; RGD:2889; -.
DR   CTD; 3606; -.
DR   RGD; 2889; Il18.
DR   eggNOG; ENOG502SDJZ; Eukaryota.
DR   InParanoid; P97636; -.
DR   PhylomeDB; P97636; -.
DR   TreeFam; TF336297; -.
DR   Reactome; R-RNO-448706; Interleukin-1 processing.
DR   Reactome; R-RNO-5620971; Pyroptosis.
DR   Reactome; R-RNO-9012546; Interleukin-18 signaling.
DR   PRO; PR:P97636; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005125; F:cytokine activity; ISS:UniProtKB.
DR   GO; GO:0045515; F:interleukin-18 receptor binding; ISS:UniProtKB.
DR   GO; GO:0048018; F:receptor ligand activity; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0071374; P:cellular response to parathyroid hormone stimulus; IEP:RGD.
DR   GO; GO:0071375; P:cellular response to peptide hormone stimulus; IMP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0071346; P:cellular response to type II interferon; IEP:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; ISS:UniProtKB.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IDA:RGD.
DR   GO; GO:0048546; P:digestive tract morphogenesis; IEP:RGD.
DR   GO; GO:0061436; P:establishment of skin barrier; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0035655; P:interleukin-18-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007611; P:learning or memory; TAS:RGD.
DR   GO; GO:0097421; P:liver regeneration; IEP:RGD.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0030101; P:natural killer cell activation; ISO:RGD.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0045662; P:negative regulation of myoblast differentiation; ISO:RGD.
DR   GO; GO:0033030; P:negative regulation of neutrophil apoptotic process; IMP:RGD.
DR   GO; GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; IMP:RGD.
DR   GO; GO:0042119; P:neutrophil activation; ISO:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; IEP:RGD.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:2000504; P:positive regulation of blood vessel remodeling; IDA:RGD.
DR   GO; GO:0032722; P:positive regulation of chemokine production; IMP:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; ISO:RGD.
DR   GO; GO:2000347; P:positive regulation of hepatocyte proliferation; IDA:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; IEP:RGD.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; ISO:RGD.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; IDA:RGD.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; ISO:RGD.
DR   GO; GO:2000256; P:positive regulation of male germ cell proliferation; IDA:RGD.
DR   GO; GO:0032819; P:positive regulation of natural killer cell proliferation; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0051142; P:positive regulation of NK T cell proliferation; ISO:RGD.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IMP:RGD.
DR   GO; GO:2000556; P:positive regulation of T-helper 1 cell cytokine production; ISS:UniProtKB.
DR   GO; GO:0045630; P:positive regulation of T-helper 2 cell differentiation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; IMP:RGD.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; ISS:UniProtKB.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISO:RGD.
DR   GO; GO:0043117; P:positive regulation of vascular permeability; IMP:RGD.
DR   GO; GO:0030155; P:regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0045188; P:regulation of circadian sleep/wake cycle, non-REM sleep; TAS:UniProtKB.
DR   GO; GO:0055093; P:response to hyperoxia; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IMP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0030431; P:sleep; IDA:UniProtKB.
DR   GO; GO:0042088; P:T-helper 1 type immune response; ISS:UniProtKB.
DR   GO; GO:0070328; P:triglyceride homeostasis; ISO:RGD.
DR   Gene3D; 2.80.10.50; -; 1.
DR   InterPro; IPR015529; IL-18.
DR   InterPro; IPR000975; IL-1_fam.
DR   InterPro; IPR008996; IL1/FGF.
DR   PANTHER; PTHR10078; INTERLEUKIN-1 FAMILY MEMBER; 1.
DR   PANTHER; PTHR10078:SF35; INTERLEUKIN-18; 1.
DR   Pfam; PF00340; IL1; 1.
DR   PIRSF; PIRSF015162; Interleukin_18; 1.
DR   PRINTS; PR01933; INTRLEUKIN18.
DR   SUPFAM; SSF50353; Cytokine; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cytokine; Cytoplasm; Inflammatory response;
KW   Reference proteome; Secreted.
FT   PROPEP          1..36
FT                   /evidence="ECO:0000250|UniProtKB:P70380"
FT                   /id="PRO_0000015349"
FT   CHAIN           37..194
FT                   /note="Interleukin-18"
FT                   /id="PRO_0000015350"
FT   SITE            36..37
FT                   /note="Cleavage; by CASP1"
FT                   /evidence="ECO:0000250|UniProtKB:Q14116"
FT   SITE            71..72
FT                   /note="Cleavage; by CASP3"
FT                   /evidence="ECO:0000250|UniProtKB:Q14116"
FT   VAR_SEQ         121..139
FT                   /note="Missing (in isoform Alpha)"
FT                   /evidence="ECO:0000303|PubMed:8999896"
FT                   /id="VSP_002659"
FT   CONFLICT        4..5
FT                   /note="MS -> IP (in Ref. 2; CAA11001 and 4; AAL77211)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        48
FT                   /note="I -> M (in Ref. 2; CAA11001 and 4; AAL77211)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   194 AA;  22303 MW;  E2089AD6F1798450 CRC64;
     MAAMSEEGSC VNFKEMMFID NTLYLIPEDN GDLESDHFGR LHCTTAVIRS INDQVLFVDK
     RNPPVFEDMP DIDRTANESQ TRLIIYMYKD SEVRGLAVTL SVKDGRMSTL SCKNKIISFE
     EMNPPENIDD IKSDLIFFQK RVPGHNKMEF ESSLYEGHFL ACQKEDDAFK LVLKRKDENG
     DKSVMFTLTN LHQS
//
